TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25841891

Group type: COMPARATOR
Intervention: Intramuscular procaine benzylpenicillin and gentamicin once per day for 7 days (group A)
Number of subjects: 2490

Group type: EXPERIMENTAL
Intervention: Intramuscular gentamicin once per day and oral amoxicillin twice per day for 7 days (group B)
Number of subjects: 2490

Group type: EXPERIMENTAL
Intervention: Intramuscular procaine benzylpenicillin and gentamicin once per day for 2 days, then oral amoxicillin twice per day for 5 days (group C)
Number of subjects: 2490

Group type: COMPARATOR
Intervention: Group A (standard treatment)
Number of subjects: 2490

Group type: EXPERIMENTAL
Intervention: Group B (alternative regimen)
Number of subjects: 2490

Group type: EXPERIMENTAL
Intervention: Group C (alternative regimen)
Number of subjects: 2490

Group type: COMPARATOR
Intervention: Group A
Number of subjects: 2490

Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 2490

Group type: EXPERIMENTAL
Intervention: Group C
Number of subjects: 2490
Study: 24105909

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 393
Study: 21671851

Group type: EXPERIMENTAL
Intervention: Disease-modifying drugs (DMDs) for RRMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 19473411

Group type: EXPERIMENTAL
Intervention: BDDrFVIII
Number of subjects: 204
Study: 17364435

Group type: EXPERIMENTAL
Intervention: In-person ALSFRS-R interviews
Number of subjects: 68

Group type: COMPARATOR
Intervention: Telephone administration of ALSFRS-R
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Primary raters scoring
Number of subjects: 68

Group type: COMPARATOR
Intervention: Back-up raters scoring
Number of subjects: 68
Study: 15051844

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplements (MM), n = 142
Number of subjects: 453

Group type: COMPARATOR
Intervention: Iron-only supplements (FE), n = 148
Number of subjects: 453
Study: 11173790

Group type: EXPERIMENTAL
Intervention: GV 800 mg/400 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: GV 800 mg/200 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 9060194

Group type: EXPERIMENTAL
Intervention: Ethanol (0.75 ml/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Imaginal and in vivo presentations of smoking and non-smoking stimuli
Number of subjects: 60
Study: 2202619

Group type: EXPERIMENTAL
Intervention: Group A (4 x 1 tablet a day, 800 mg total daily dose)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group B (2 x 2 tablets a day, 800 mg total daily dose)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Group C (2 x 1 tablet a day, 400 mg total daily dose)
Number of subjects: 36
Study: 7196807

Group type: EXPERIMENTAL
Intervention: Cisplatin 30 mg/m2
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cisplatin 90 mg/m2
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cisplatin 30 mg/m2 and 90 mg/m2
Number of subjects: 28
Study: 30716599

Group type: EXPERIMENTAL
Intervention: Self-rated Y-BOCS
Number of subjects: 128

Group type: COMPARATOR
Intervention: Clinician-rated Y-BOCS
Number of subjects: 128
Study: 28910233

Group type: EXPERIMENTAL
Intervention: Beef protein (20 g mixed with plain water once a day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whey protein (20 g mixed with plain water once a day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Carbohydrate (20 g mixed with plain water once a day)
Number of subjects: 24
Study: 26727743

Group type: EXPERIMENTAL
Intervention: quinapril
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: amlodipine
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: hydrochlorothiazide
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: losartan
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: bisoprolol
Number of subjects: 95
Study: 25305374

Group type: EXPERIMENTAL
Intervention: Supervised progressive resistance training (PRT) 2 days/week + unsupervised home-based exercise 5 days/week
Number of subjects: 73

Group type: COMPARATOR
Intervention: Unsupervised home-based exercise 7 days/week
Number of subjects: 73
Study: 22232507

Group type: EXPERIMENTAL
Intervention: Engagement (awareness plans)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard Care (schedule setting, commitment)
Number of subjects: 117
Study: 20190313

Group type: EXPERIMENTAL
Intervention: Internal fixation
Number of subjects: 450

Group type: COMPARATOR
Intervention: Replacement (total hip replacement or hemiarthroplasty)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Both groups (Internal fixation and Replacement)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Successfully healed fractures
Number of subjects: 450

Group type: COMPARATOR
Intervention: Uncomplicated replacement
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Primary replacement
Number of subjects: 450
Study: 18575293

Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT plus 20 mg lidocaine
Number of subjects: 270

Group type: COMPARATOR
Intervention: Propofol-MCT/LCT alone
Number of subjects: 270
Study: 15814758

Group type: EXPERIMENTAL
Intervention: Neck brace
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no neck brace)
Number of subjects: 100
Study: 11920317

Group type: EXPERIMENTAL
Intervention: 9-valent pneumococcal conjugate vaccine
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 264
Study: 10715674

Group type: EXPERIMENTAL
Intervention: Primaquine 45 mg (given on day 8)
Number of subjects: 90
Study: 8610914

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 173

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study: 1443840

Group type: EXPERIMENTAL
Intervention: Transcutaneous cardiac pacing using low-impedance defibrillation-type polymer electrode pads
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transcutaneous cardiac pacing at 125% intensity for two minutes
Number of subjects: 30
Study: 4052276

Group type: EXPERIMENTAL
Intervention: Intravenous and oral propranolol (n = 44)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional therapy (n = 35)
Number of subjects: 79
Study: 30552595

Group type: EXPERIMENTAL
Intervention: Reflexology intervention (four weekly sessions, 30 min each)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Reflexology intervention
Number of subjects: 256

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 256
Study: 29695211

Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplementation (ONS) plus Dietary Counselling (DC)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Dietary Counselling (DC) alone
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: ONS consumption during follow-up
Number of subjects: 203
Study: 27163534

Group type: EXPERIMENTAL
Intervention: Pulsatile flow (Group I, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonpulsatile flow (Group II, n=20)
Number of subjects: 40
Study: 23686730

Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.5 mg/kg) plus oral ketamine (5 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral midazolam (0.5 mg/kg) plus oral placebo
Number of subjects: 60
Study: 22343469

Group type: EXPERIMENTAL
Intervention: INVOS 5100C-PB
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FORE-SIGHT
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EQUANOX Classic 7600
Number of subjects: 12
Study: 20827654

Group type: EXPERIMENTAL
Intervention: Pull up action during cycling
Number of subjects: 9
Study: 17055081

Group type: EXPERIMENTAL
Intervention: Rate control with pharmacological heart rate frequency optimization treatment combined with Holter monitoring
Number of subjects: 205

Group type: COMPARATOR
Intervention: Rhythm control with sinus rhythm restoration and sequential antiarrhythmic drug treatment
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 205

Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 205
Study: 15475602

Group type: EXPERIMENTAL
Intervention: Isometric contraction at 35 degrees (short length)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Isometric contraction at 75 degrees (long length)
Number of subjects: 11
Study: 12173678

Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling for mammography
Number of subjects: 1367

Group type: EXPERIMENTAL
Intervention: Tailored mailed materials promoting mammography
Number of subjects: 1367

Group type: EXPERIMENTAL
Intervention: Combination of tailored mail and telephone counseling
Number of subjects: 1367

Group type: COMPARATOR
Intervention: Usual care (no intervention)
Number of subjects: 1367
Study: 9872350

Group type: EXPERIMENTAL
Intervention: Alcohol-dependent subjects
Number of subjects: 12

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 12
Study: 7789590

Group type: EXPERIMENTAL
Intervention: 2 mg vaginal PGE2 gel
Number of subjects: 68

Group type: COMPARATOR
Intervention: 0.5 mg intracervical PGE2
Number of subjects: 68
Study: 2261388

Group type: EXPERIMENTAL
Intervention: Whole abdominal radiotherapy (n = 56)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Chlorambucil (n = 53)
Number of subjects: 109
Study: 7430701

Group type: EXPERIMENTAL
Intervention: Sunscreens with different sun protection factors
Number of subjects: 0
Study: 31530607

Group type: EXPERIMENTAL
Intervention: Central line removal at 100 mL/kg/day of enteral intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group: Central line removal at 140 mL/kg/day of enteral intake
Number of subjects: 0
Study: 27875389

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Gabapentin (GP)
Number of subjects: 58
Study: 25660340

Group type: COMPARATOR
Intervention: Educational group (E)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation therapy (PMR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: PMR plus exercise (PMR Plus)
Number of subjects: 44
Study: 23610236

Group type: EXPERIMENTAL
Intervention: Symbolic play then joint attention intervention
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Joint attention then symbolic play intervention
Number of subjects: 33

Group type: COMPARATOR
Intervention: Wait-list control period
Number of subjects: 33
Study: 21334013

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass
Number of subjects: 200

Group type: COMPARATOR
Intervention: On-pump coronary artery bypass
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Early brain magnetic resonance imaging
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Follow-up imaging
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 200
Study: 19253084

Group type: EXPERIMENTAL
Intervention: 50% one‐repetition maximum (1‐RM)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 75% one‐repetition maximum (1‐RM)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 90% one‐repetition maximum (1‐RM)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 110% one‐repetition maximum (1‐RM)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 35
Study: 17091205

Group type: EXPERIMENTAL
Intervention: Dust spiked with glucan
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dust spiked with aldehydes
Number of subjects: 36

Group type: COMPARATOR
Intervention: Clean air or office dust
Number of subjects: 36

Group type: COMPARATOR
Intervention: Office dust or clean air
Number of subjects: 36
Study: 14764189

Group type: EXPERIMENTAL
Intervention: Music therapy (twice a week for 8 weeks, total of 16 sessions)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 10
Study: 11318841

Group type: EXPERIMENTAL
Intervention: Kir6.2 E23K variant
Number of subjects: 692

Group type: COMPARATOR
Intervention: SUR1 promoter variants
Number of subjects: 692
Study: 9597863

Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) administered on the day of operation
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) administered for 3 days
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) or cefotiam (CTM) administered for 2 days
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) or cefotiam (CTM) administered for 4 days
Number of subjects: 255

Group type: COMPARATOR
Intervention: Shorter antimicrobial administration periods
Number of subjects: 255
Study: 7940731

Group type: EXPERIMENTAL
Intervention: T cell depletion using anti-CD8 and anti-CD6 antibodies plus complement (n = 28)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Methotrexate (MTX) and cyclosporine (CsA) (n = 25)
Number of subjects: 48
Study: 3024542

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 100
Study: 29409737

Group type: EXPERIMENTAL
Intervention: Standing desk intervention (16 weeks duration)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (traditional seated desks)
Number of subjects: 49
Study: 27793147

Group type: EXPERIMENTAL
Intervention: Combined microsavings and HIV/STI risk reduction intervention (treatment condition)
Number of subjects: 107

Group type: COMPARATOR
Intervention: HIV/STI risk reduction intervention (control condition)
Number of subjects: 107
Study: 25704020

Group type: EXPERIMENTAL
Intervention: Olmesartan (morning), n = 13
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Olmesartan (evening), n = 15
Number of subjects: 40

Group type: COMPARATOR
Intervention: Valsartan (evening), n = 12
Number of subjects: 40
Study: 22539383

Group type: EXPERIMENTAL
Intervention: Closed high-pressure suction drainage
Number of subjects: 120

Group type: COMPARATOR
Intervention: Presacral drainage
Number of subjects: 120
Study: 20567051

Group type: EXPERIMENTAL
Intervention: Pressurized topical oxygen therapy (TWO(2)), 60-minute treatment, five times per week, pressure cycles between 5 and 50 mb
Number of subjects: 28

Group type: COMPARATOR
Intervention: Silver-containing dressing, changed at least twice per week (control)
Number of subjects: 28
Study: 18404673

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both agents
Number of subjects: 0
Study: 15892445

Group type: EXPERIMENTAL
Intervention: Chinese version of the Short‐Form 36 Health Survey (SF‐36) Physical Functioning (PF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chinese version of the Short‐Form 36 Health Survey (SF‐36) Physical Component Summary (PCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: English version of the Short‐Form 36 Health Survey (SF‐36) Physical Functioning (PF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: English version of the Short‐Form 36 Health Survey (SF‐36) Physical Component Summary (PCS)
Number of subjects: 0
Study: 12550014

Group type: EXPERIMENTAL
Intervention: BIPAP support pressure device
Number of subjects: 10

Group type: COMPARATOR
Intervention: Volumetric ventilator
Number of subjects: 10
Study: 10485768

Group type: EXPERIMENTAL
Intervention: Tidal volume breathing for 3 min at 5 l/min
Number of subjects: 56

Group type: COMPARATOR
Intervention: Four deep breaths for 30 s at 5 l/min
Number of subjects: 56

Group type: COMPARATOR
Intervention: Four deep breaths for 30 s at 10 l/min
Number of subjects: 56

Group type: COMPARATOR
Intervention: Four deep breaths for 30 s at 20 l/min
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Eight deep breaths for 60 s at 10 l/min
Number of subjects: 56

Group type: COMPARATOR
Intervention: Traditional technique (3 min tidal volume breathing)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Apnea following eight deep breaths technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Apnea following traditional technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Apnea following four deep breaths technique
Number of subjects: 56
Study: 7575750

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 1000 mg/Thioctacid/500 ml NaCl
Number of subjects: 13

Group type: COMPARATOR
Intervention: Vehicle control (500 ml NaCl)
Number of subjects: 13
Study: 1838235

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no diclofenac)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic sterilisation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative side effects
Number of subjects: 0
Study: 28545

Group type: EXPERIMENTAL
Intervention: ID-540 (0.5 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: N-Desmethyl-ID-540
Number of subjects: 6
Study: 31561819

Group type: EXPERIMENTAL
Intervention: 3-monthly replacement group
Number of subjects: 60

Group type: COMPARATOR
Intervention: 6-monthly replacement group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 27470115

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 µg/kg IV over 10 min before anesthesia induction, followed by 0.7 µg/kg/h infusion during operation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Remifentanil 1 µg/kg IV bolus with induction of anesthesia, continued 0.25-0.50 µg/kg/min during operation
Number of subjects: 50
Study: 26245861

Group type: EXPERIMENTAL
Intervention: 3D animated tour of the third ventricle with the DextroBeam
Number of subjects: 169

Group type: COMPARATOR
Intervention: 2D PowerPoint presentation
Number of subjects: 169
Study: 23520223

Group type: EXPERIMENTAL
Intervention: Postcard intervention (eight in 12 months) plus treatment as usual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 21628666

Group type: EXPERIMENTAL
Intervention: AS03(A)-adjuvanted H1N1v vaccine (3.75 μg HA)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Nonadjuvanted H1N1v vaccine (15 μg HA)
Number of subjects: 306
Study: 19398387

Group type: EXPERIMENTAL
Intervention: Epidural injections with varying volumes
Number of subjects: 15

Group type: COMPARATOR
Intervention: Epidural injections with the same volume
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Epidural injections with different volumes
Number of subjects: 15
Study: 17303369

Group type: EXPERIMENTAL
Intervention: Walking program with pedometer (WPP)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Walking program (WP)
Number of subjects: 369

Group type: COMPARATOR
Intervention: No-treatment control group (C)
Number of subjects: 369
Study: 14725511

Group type: EXPERIMENTAL
Intervention: Acute normovolemic haemodilution (ANH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 11799593

Group type: EXPERIMENTAL
Intervention: Sibutramine (Reductil‐Abbott Laboratories)
Number of subjects: 0
Study: 9489535

Group type: EXPERIMENTAL
Intervention: Posterior fossa decompression surgery
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (age and sex matched)
Number of subjects: 9
Study: 7908865

Group type: EXPERIMENTAL
Intervention: Conventional intravenous nutrition (0.2 g of N and 103 non-protein kJ/kg body weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous saline (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous nutrition enriched with branched-chain amino acids (0.2 g of N with 30% from branched-chain amino acids and 103 non-protein kJ/kg body weight)
Number of subjects: 0
Study: 3421250

Group type: EXPERIMENTAL
Intervention: Ampicillin prophylaxis (n = 43)
Number of subjects: 82

Group type: COMPARATOR
Intervention: No ampicillin prophylaxis (n = 39)
Number of subjects: 82
Study: 31846901

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 38
Study: 29655984

Group type: EXPERIMENTAL
Intervention: Motor affordance program at home for infants (G-2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Motor affordance program at home for infants (G-1)
Number of subjects: 14
Study: 28000689

Group type: EXPERIMENTAL
Intervention: Salba-chia (25g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flax (31.5g)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Glucose control
Number of subjects: 15
Study: 26224039

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy and surgery
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 38
Study: 23193161

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 174
Study: 21986137

Group type: EXPERIMENTAL
Intervention: Continuous local infiltration analgesia (CLIA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single-injection local infiltration analgesia (SLIA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 80
Study: 18800207

Group type: EXPERIMENTAL
Intervention: Self-guided group (SG) who were given an advance directive (AD) and written instructions
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (CG) who were given the same material but offered guidance to complete the AD
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (AD completers)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (non-AD completers)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: AD completers
Number of subjects: 59
Study: 17986327

Group type: EXPERIMENTAL
Intervention: no added salt diet
Number of subjects: 80
Study: 15379315

Group type: EXPERIMENTAL
Intervention: six flavor glutinous rehmannis pill
Number of subjects: 120
Study: 11858103

Group type: EXPERIMENTAL
Intervention: Tiklid
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 30
Study: 9020492

Group type: EXPERIMENTAL
Intervention: Initial serum concentrations of HCG > 1000 IU l(‐1)
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Initial serum concentrations of AFP > 1000 IU l(‐1)
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Half-lives of HCG > 3 days
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Half-lives of AFP > 6 days
Number of subjects: 669
Study: 7885970

Group type: EXPERIMENTAL
Intervention: Treatment A (100 mg ZDV after an 8-hour fast)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Treatment B (100 mg ZDV with a high-fat breakfast)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Treatment C (100 mg ZDV 3 hours after a high-fat breakfast)
Number of subjects: 18